搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
Armed robbery in Revesby
6 小时
Research: Xenon Gas Shows Promise in Alzheimer's Treatment
An inert and unreactive gas may not seem like an obvious candidate for treating Alzheimer's disease, yet a new study in mice suggests that xenon ...
7 小时
Might Xenon gas be useful for treating Alzheimer’s, as a new study suggests?
Xenon is one of the six noble gases. Its name derives from the Greek word for “strange”. In medicine, it has been used as an ...
14 小时
Ncardia Launches Ncyte® Microglia to Advance Research in Neurodegenerative Diseases
Ncardia, a global leader in human induced pluripotent stem cell (hiPSC) technology, today announced the launch of Ncyte® ...
Medindia
19 小时
Microglia's Sex-Specific Responses in Brain Disorders
New research reveals that microglia respond differently in male and female brains for brain disorders like Alzheimer's and ...
ALZFORUM
3 天
“iAssembloids” Probe Glial Roles in Neuron Survival
Sphere of Influence. In iAssembloids, microglia (red) form projections (white arrows), while astrocytes (green) assume star shapes typically found in the brain. [Courtesy of Kampmann et al., 2025.] ...
Indian Defence Review
3 天
Alzheimer: a new culprit of the disease identified by scientists
Aerobic exercise may significantly reduce Alzheimer's disease markers, with studies showing up to 76% decreases in harmful ...
News Medical
3 天
Study reveals sex-specific differences in microglial response to CSF1R inhibition
Researchers investigate the sex-dependent microglial response to a colony-stimulating factor 1 receptor (CSF1R) inhibitor.
4 天
Inhalation of xenon gas shows promise as a neuroprotective treatment for Alzheimer's Disease
Xenon gas, currently used in medicine as an anesthetic and neuroprotective agent for treating brain injuries, showed ...
BioSpace
4 天
Vigil’s TREM2-Targeted Alzheimer’s Treatment Shows Early Promise, Moves On to Phase II
Vigil Neuroscience reported a strong safety profile and 50% sTREM2 reduction in an early-stage trial for VG-3927, potentially ...
4 天
Vigil Neuroscience’s VG-3927: Promising Phase 1 Results and Strategic Positioning for Phase 2
Jason Butler, an analyst from JMP Securities, reiterated the Buy rating on Vigil Neuroscience Inc (VIGL – Research Report). The associated ...
4 天
Vigil Neuroscience Reports Positive Data from its Phase 1 Clinical Trial Evaluating VG-3927 ...
Safety, tolerability, pharmacokinetic, and pharmacodynamic profile supports continued development of VG-3927 as potential ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈